Pelham Smithers Associates Ltd - PSA Today 16 May: Progress despite adverse earnings / Lecanemab vs Donanemab / Looking at Micron etc / Daifuku rallies / Net Protections strategy / Promising Freee – Nikkei 225 +0.73%

Report

Pelham Smithers Associates Ltd

Joel Scheiman ...

Julie Boote
Lindsay Whipp
Pelham Smithers
Thao Nguyen
William Nestuk

PSA Today 16 May: Progress despite adverse earnings / Lecanemab vs Donanemab / Looking at Micron etc / Daifuku rallies / Net Protections strategy / Promising Freee – Nikkei 225 +0.73%

Japan Market Comment by Pelham Smithers, Julie Boote, Joel Scheiman, William Nestuk, Thao Nguyen and Lindsay Whipp
Tags: Micron (MU US), AMD (AMD US), Western Digital (WDC US), Toshiba (6502 JT), Kioxia, Renesas (6723 JT), Advantest (6857 JT), Tokyo Electron (8035 JT), Hoya (7741 JT), Kanto Denka Kogyo (4047 JT), Samsung Electronics (005930 KS), Sony (6758 JT), Konica Minolta (4902 JT), Dentsu (4324 JT), Tsuburaya Fields (2767 JT), Sega Sammy (6460 JT), Konami (9766 JT), Suzuki Motor (7269 JT), Mitsubishi Motors (7211 JT), Sekisui Chemical (4204 JT), Rakuten (4755 JT), KDDI (9433 JT), Rakuten Bank (5838 JT), Eisai (4523 JT), Biogen (BIIB US), Eli Lilly (LLY US), TSMC (2330 TT), Apple (AAPL US), Nvidia (NVDA US), Broadcom (AVGO US), Daifuku (6383 JT), Net Protections (7383 JT), Freee KK (4478 JT), Money Forward (3994 JT)
Main Points
• Nikkei 225 closing in on 30,000 despite adverse earnings numbers
• Lecanemab vs Donanemab: Straight race or separate tracks?
• Micron hopes spark SOX despite further falls in memory prices
• Daifuku recovers yesterday’s losses on broker upgrade
• Net Protections sold off as the company prioritises investment for growth
• Solid FY23 Q3 sales and KPIs for Freee

16/05/2023 1 EN

Provider

Pelham Smithers Associates Ltd

Founded in 2009, Pelham Smithers Associates (PSA) provides market intelligence on Asian technology, focusing in particular on Japan. The industries covered by our team of specialists are: consumer electronics, telecomms, pharmaceuticals, internet, electronic parts and materials, automotive technology, retail and capital goods.

PSA produces both company and sector reports. The focus of PSA’s research is to identify winners and losers as new technologies impact the top and bottom lines of corporations. Critical to our research is the clear explanation of how these new technologies work and how they impact companies and industries.

The founding partners have worked closely together for twenty years and the team has more than doubled in size since 2012.

See profile

Analysts

Joel Scheiman

Julie Boote

Lindsay Whipp

Pelham Smithers

Thao Nguyen

William Nestuk

Other Reports from Pelham Smithers Associates Ltd

Hiroyuki Terada ... (+8)

Hiroyuki Terada
Joel Scheiman
Julie Boote
Lindsay Whipp
Nia Dokova
Pelham Smithers
Thao Nguyen
William Nestuk

The PSA Research Round-Up for the Two-Week Period Covering 11~25 April 2025

Weekly Comment Summary Two weeks ago, we wrote here about how US trade policy was generating a very “top down” market. Since then, uncertainty has replaced fear, and this has led to a very “bottom up" market, with the winners those delivering good / better-than-expected news, explains Pelham Smithers. PSA Company Visits, Tours and Interviews Visited: TKP (3479 JT), JINS Holdings (3046 JT), Treasure Factory (3093 JT), Koshidaka Holdings (2157 JT) 1-1 Call with: Insource (6200 JT) Presentations at: Shin-Etsu Chemical (4063 JT), Nitto Denko (6988 JT), Fujifilm Holdings (4901 JT), Zeon Corp...

April 25, 2025 April 25, 2025 1 EN

Hiroyuki Terada

Hiroyuki Terada

PSA Broadline Retail: Treasure Factory (3093 JT): Inbound Sales Still Solid in Q1

Second-hand retailer Treasure Factory has an advantage over mainstream luxury goods retailers, explains analyst Hiroyuki Terada in this update which adjusts PSA’s forecasts downwards and introduces our FY27 numbers.

April 25, 2025 April 25, 2025 1 EN

Joel Scheiman ... (+6)

Joel Scheiman
Julie Boote
Lindsay Whipp
Nia Dokova
Pelham Smithers
William Nestuk

PSA Today 25 Apr: Most of tariff fall recouped now / Tokyo CPI / Analyst articles on Advantest, Nissan, Hino, Denso, HCM, NRI, NTT Data, Chugai, DSK – Nikkei 225 +1.90% | ¥$143.55

PSA Today Japan Market Comment by Pelham Smithers, Julie Boote, Joel Scheiman, William Nestuk, Lindsay Whipp and Nia Dokova Tags: Renesas (6723 JT), Fujikura (5803 JT), Furukawa Electric (5801 JT), Nidec (6594 JT), Fujitsu (6702 JT), Hitachi (6501 JT), NEC Corp (6701 JT), Canon (7751 JT), Shin-Etsu Chemical (4063 JT), Zeon Corp (4205 JT), Tokyo Steel (5423 JT), Daiichi Sankyo (4568 JT), Chugai Pharmaceutical (4519 JT), Advantest (6857 JT), Teradyne (TER US), Lam Research (LRCX US), Tokyo Seimitsu (7729 JT), Ulvac (6728 JT), Nissan Motor (7201 JT), Honda Motor (7267 JT), Hino Motors (7205 JT...

April 25, 2025 April 25, 2025 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

PSA Today 16 May: Progress despite adverse earnings / Lecanemab vs Donanemab / Looking at Micron etc / Daifuku rallies / Net Protections strategy / Promising Freee – Nikkei 225 +0.73%

The PSA Research Round-Up for the Two-Week Period Covering 11~25 April 2025

PSA Broadline Retail: Treasure Factory (3093 JT): Inbound Sales Still Solid in Q1

PSA Today 25 Apr: Most of tariff fall recouped now / Tokyo CPI / Analyst articles on Advantest, Nissan, Hino, Denso, HCM, NRI, NTT Data, Chugai, DSK – Nikkei 225 +1.90% | ¥$143.55

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe